The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. - Wikidata - wikimedia - TriplyDB

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

http://www.wikidata.org/entity/Q37419709

about

Role of epithelial-mesenchymal transition in gastric cancer initiation and progression Novel approaches in anaplastic thyroid cancer therapy Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling.Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells.TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.SMAD7: a timer of tumor progression targeting TGF-β signaling.Modeling anaplastic thyroid carcinoma in the mouse.MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1.Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors.Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma.Atypical adenoma of the thyroid diagnosed as anaplastic cancer by cytopathology.Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.

P2860

Q33594912-2F247397-F0A5-47DB-9A40-DCB91145DCFA Q34458018-78BF02AB-9903-466C-9CBF-807AA6CD0137 Q35145140-0D95FD8D-E92A-4461-B29B-39600ECC9F0D Q36032766-F17C9346-10CF-440E-BE57-117BE5E44794 Q36282408-5BF61F5E-0FF5-4DF0-9973-A1A2E26AD149 Q37688532-B7EAC12F-2D13-467E-99C8-06DC64C0DD7B Q37688577-A4C7A7AE-80A3-4800-B108-6B9D6018C80B Q38220764-9C835492-4E70-40A9-B92B-EC8A21743970 Q38270915-E45F2A9A-5CF9-4C61-BD0E-1EEA1DF99ABA Q38718003-74FD8A2B-0DB7-4AAA-924F-5271941C0D78 Q38833693-402F2EA3-E1A8-4F5F-9CE3-7F13831289B8 Q38838174-D7173FF0-286E-4EB1-AC5F-CB10E8EFB10F Q38980944-A1AAF8FF-E3AC-4D13-AA77-4A43CB0E2B8A Q39231590-7DDB8D43-7FA9-4B0E-B240-B4CB46CCC02C Q47146386-F5D1BB05-07B1-4495-A6C8-2825AA841316 Q47752682-0C69F562-3B88-416A-B949-D84DB60AFCB0 Q49221322-647F4176-E989-4BC8-9E05-E37C3998A00B Q49569565-0FDCDCFA-FC63-4945-8C99-B90DCA8A686F Q49670720-B28AAACF-2E79-4BE7-BED6-39AF61CBB433 Q55345025-FB1CDBDC-D0C0-4369-A075-95EF22803D36

P2860

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

http://www.wikidata.org/entity/Q37419709

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@en

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@nl

type

label

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@en

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@nl

prefLabel

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@en

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

@nl

P1433

Q37419709-BC8A6E4A-EADD-438F-A303-FD39D3D35FAC

P1476

Q37419709-A5B74121-C47D-4069-B01F-D64D828B6384

P2093

Q37419709-1C8B99A7-C914-4B07-9CE7-D75AF22A4696

Q37419709-499C58AA-44AF-4082-877C-DFBD5368B77F

Q37419709-5A31A8D8-14A0-483E-9313-CE20A9486260

Q37419709-5FF604BC-1652-45FD-A169-F170AC255FBA

Q37419709-6D2D15DD-5422-4ED6-A5FE-E827065B6346

Q37419709-82FC8D30-8CC5-4732-A8A6-CC8371AD8B8C

Q37419709-A8AB9E7E-BFE1-439A-BE9C-7F48D3E34E1C

P2860

Q37419709-0432CCCB-84BE-4A1D-9703-FF6D88355236

Q37419709-15192BF3-6E49-423D-8F31-A07F4EC528C1

Q37419709-1A897660-8C86-40D5-9206-A011D14C4F07

Q37419709-28D5F570-32F9-4D38-AC7C-BC9A8CF4C110

Q37419709-3253C5EC-8868-48F5-A33F-356E52746290

Q37419709-46FA867F-36B7-4214-B123-36F16941A23A

Q37419709-4A698A73-6E15-41AB-B4C5-E7A63B704429

Q37419709-502718BF-5DAF-4CAC-8DBB-23791425FCDB

Q37419709-5509584B-CAFE-42A0-A4CB-3B95A10E89FC

Q37419709-5D6218DD-11D3-41F1-B6E4-3C1062C70FCE

P2888

Q37419709-DCE762CA-F564-4D77-AD5F-6B802E75550B

P304

Q37419709-33FFDBEB-0C98-43F3-B4CE-793E2E8074C4

P31

Q37419709-AF871A83-4753-435C-9334-B4C4FCA51713

P356

Q37419709-D1B397D2-ABB7-4435-9140-3357FFA2ECCE

P433

Q37419709-3C55C803-A372-4C65-A0F2-DFD18EDB9546

P478

Q37419709-53E28A70-70C3-43FD-89AD-2EA6940D1E30

P50

Q37419709-FAC12AC6-29F8-4EEC-B28D-5FBB5F78EA7C

P577

Q37419709-7633E5E3-0460-44BF-A938-1068DFC24633

P5875

Q37419709-46A38ED7-D642-481E-BDFD-C3D497291758

P698

Q37419709-126BF4D5-C720-469D-B096-6E129E4C9D1F

P932

Q37419709-3929510E-BD6E-4389-B56F-116E81D78DB9

P356

S12022-013-9272-9

P1433

Endocrine Pathology

P1476

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression

@en

P2093

Carolina Larrain

http://www.w3.org/2001/XMLSchema#string

Celina Montemayor-Garcia

http://www.w3.org/2001/XMLSchema#string

Darya Buehler

http://www.w3.org/2001/XMLSchema#string

Heather Hardin

http://www.w3.org/2001/XMLSchema#string

Herbert Chen

http://www.w3.org/2001/XMLSchema#string

Ricardo V Lloyd

http://www.w3.org/2001/XMLSchema#string

Zhenying Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

Epithelial-mesenchymal transitions in development and disease

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

TGFβ signalling in context

Transforming growth factor beta1 induces nuclear export of inhibitory Smad7

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.

P2888

s12022-013-9272-9

P304

206-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12022-013-9272-9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257814293

http://www.w3.org/2001/XMLSchema#string

P698

24126800

http://www.w3.org/2001/XMLSchema#string

P932

3875396

http://www.w3.org/2001/XMLSchema#string